IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
VRAX News
Archived Headlines
- US IPO Week Ahead: More small IPOs in the first full week of the 3Q 07/08/22
- Diagnostics and PPE provider Virax Biolabs increases proposed share offering ahead of $7 million US IPO 06/21/22
- Diagnostics and PPE provider Virax Biolabs sets terms for $6 million US IPO 06/07/22
- US IPO Weekly Recap: Cannabis micro-cap breaks the IPO market's dry spell 03/18/22
- Diagnostics and PPE provider Virax Biolabs Group files for a $17 million US IPO 03/18/22
Renaissance Capital’s July IPO Market Update
Seven IPOs raised a combined $228 million in the slowest July in what’s shaping up to be the slowest year for the IPO market in over a decade. Five of the seven offerings came from foreign issuers, led by Chinese fintech AMTD Digital....read more
US IPO Weekly Recap: E-commerce and diagnostics debut in a 2 IPO Week
Two IPOs began trading in another quiet week for the IPO market. In the pipeline, two IPOs and one SPAC submitted initial filings. Chinese e-commerce play WeTrade Group (WETG) priced at the low end to raise $40 million at a $780 million market cap. WeTrade operates a membership-based platform where it provides technical services and solutions. While the company...read more
Diagnostics provider Virax Biolabs prices US IPO at $5
Virax Biolabs Group, a UK-based provider of diagnostic tests and PPE for viral diseases, raised $7 million by offering 1.35 million shares at $5. Virax has operating subsidiaries in Singapore, Hong Kong, mainland China, and the British Virgin Islands. It primarily sells, distributes, and markets diagnostics test kits and med-tech and PPE products for viral diseases, serving as a...read more
US IPO Week Ahead: 1 small IPO on the calendar as slow summer continues
The IPO market’s slow summer is set to continue with one IPO scheduled to price in the week ahead. Other small deals may also join the calendar during the week. After delaying its debut this past week, Virax Biolabs (VRAX) plans to raise $7 million at a $57 million market cap. Operating in the UK and Hong Kong, Virax Biolabs provides a portfolio of...read more